At the news
? NEUTRALIMPACT 2/10 PRESS-RELEASE filed Nov 6, 2026 at 16:01 ET
BridgeBio Pharma granted 147,578 restricted stock units to 80 new employees as an inducement material to their employment, with vesting starting November 2027. This is a routine equity grant for new hires, not a material financial event.
- Compensation committee approved equity grants of 147,578 RSUs to 80 new employees on November 5, 2026.
- One-fourth of each RSU vests on November 16, 2027, with the remainder vesting quarterly thereafter.
- Grants were made as inducement material to employment under Nasdaq Listing Rule 5635(c)(4).
- The plan was adopted in November 2019 and amended in February 2023 and December 2023.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access